Overview

Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
Research to Prevent Blindness
VitreoRetinal Surgery, PA
Treatments:
Ophthalmic Solutions
Propoxycaine
Proxymetacaine